Business

PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO

PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO ...

articlePharmacielo Ltd.August 20, 20213/company/pharmacielo-ltd/news/pharmacielo-announces-q2-2021-financial-results-and-appointment-of-bill-petron-as-ceo
PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO

About this update from Pharmacielo Ltd.

[{"type":"text","content":"\n \n \n \n PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:1pt; BORDER-RIGHT:black 1pt solid; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; TEXT-ALIGN: RIGHT; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.67em\n}\n.prngen7{\nBORDER-TOP:1pt; BORDER-RIGHT:black 1pt solid; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 1pt solid; TEXT-ALIGN: RIGHT; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prngen6{\nBORDER-TOP:1pt; BORDER-RIGHT:black 1pt solid; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 1pt solid; TEXT-ALIGN: LEFT; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prnsbbs{\nBORDER-BOTTOM:black 1pt solid\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n.prnvab{\nVERTICAL-ALIGN: BOTTOM\n}\n.prnsbt1{\nBORDER-TOP:1pt\n}\n.prnrbrs{\nBORDER-RIGHT:black 1pt solid\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnpr8{\nPADDING-RIGHT:0.67em\n}\n.prnsbts{\nBORDER-TOP:black 1pt solid\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prnsbl1{\nBORDER-LEFT:1pt\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n On track for Revenue growth in the back half of fiscal 2021, as recently signed sales agreements translate into higher volumes. Generated early revenue from more than ten countries in the quarter.\n \n \n \n \n \n Bill Petron\n \n , the Company's Chairman and a global operations and cannabis veteran, has been appointed Chief Executive Officer of PharmaCielo.\n \n \n \n \n Most recently, Mr. Petron co-founded Alternative Medical Enterprises LLC, and co-led the company through its\n \n December 2020\n \n merger with Verano Holdings LLC.\n \n \n \n \n \n All figures are in Canadian dollars ($) unless otherwise specified\n \n \n \n \n TORONTO\n \n and RIONEGRO,\n \n Colombia\n \n ,\n \n Aug. 20, 2021\n \n /CNW/ -\n \n PharmaCielo Ltd.\n \n (\"\n \n PharmaCielo\n \n \" or the \"\n \n Company\n \n \") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of\n \...

More updates from Pharmacielo Ltd.